Med. praxi. 2013;10(2):64-67 [Psychiatr. praxi. 2012;13(2):61-63]

Anxiety and anxiety disorders in dementia

MUDr.Vanda Franková
Psychiatrická léčebna Dobřany

The article summarizes the basic literature knowledge concerning this issue, making reference to the Rating Anxiety in Dementia (RAID)

scale by Shankar, et al. and the revised diagnostic criteria for generalized anxiety disorder in persons with dementia as proposed by

Starkstein, et al. Also presented are some recommendations concerning psychotherapeutic approaches and pharmacotherapy of anxiety

disorders in the elderly with dementia.

Keywords: anxiety, agitation, dementia, RAID, SSRI

Published: February 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Franková V. Anxiety and anxiety disorders in dementia. Med. praxi. 2013;10(2):64-67.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Seignourel PJ, Kunik ME, Snow L, et al. Anxiety in dementia: A critical review. Clinical Psychology Review 2008; 28(7): 1071-1082. Go to original source... Go to PubMed...
    2. Lanctot KL, Herrmann N, Mazzotta P. Role of serotonin in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci 2001; 13: 5-21. Go to original source... Go to PubMed...
    3. Shankar KK, Walker M, Frost D, Orrel MW. The development of a valid and reliable scale for rating anxiety in dementia (RAID). Aging and Mental Health 1999; 3: 39-49. Go to original source...
    4. Cummings JL. The neuropsychiatric inventory: Assessing psychopathology in dementia patients. Neurology 1997; 48(Suppl 6): 10-16. Go to original source... Go to PubMed...
    5. Ferretti, et al. Anxiety and Alzheimer´s disease. J Geriatr Psychiatry Neurol 2001; 14: 52-58. Go to original source... Go to PubMed...
    6. Starkstein SE, Jorge R, Petracca G, Robinson RG. The Construct of generalized anxiety disorder in Alzheimer Disease. Am J Geriatr psychiatry 2007; 15(1): 42-49. Go to original source... Go to PubMed...
    7. Kraus CA, Seignourel P, Balasubramanyam V, et al. Cognitive-behavioral treatment for anxiety in patients with dementia. Two case studies. J Psychiatr Pract 2008; 14(3): 186-192. Go to original source... Go to PubMed...
    8. Holmes C, Ballard C. Aromatherapy in dementia. Advances in psychiatric treatment 2004; 10: 296-300. Go to original source...
    9. Van Wert JCM, Van Dulmen AM, Spreeuwenberg PMM, et al. Behavioral and mood effects of snoezelen integrated into 24-hours dementia care. Journal American of the Geriatrics Society 2005; 1: 24-33. Go to original source... Go to PubMed...
    10. Praško J, Vyskočilová J. Generalizovaná úzkostná porucha. In: Seifertová D, Praško J, Horáček J, Höschl C (eds.). Postupy v léčbě psychických poruch. Algoritmy neuropsychofarmakologické společnosti. 2. rev. vydání. Praha: Academia Medica Pragensis, 2008: 232-255.
    11. Wetherell JL, Lenze EJ, Stanley MA. Evidence-based treatment of geriatric anxiety disorders. Psychiatr Clin N Am 2005; 28: 971-896. Go to original source... Go to PubMed...
    12. Swartz M, Barak Y, Mirecki I, Naor S, Weizman A. Treating depression in Alzheimer´s disease: Integration of differing guidelines. International Psychogeriatrics 2000; 12(3): 353-358. Go to original source... Go to PubMed...
    13. Horáček J. Účinnost a bezpečnost escitalopramu u osob ve vyšším věku: spojená (poolovaná) analýza pěti otevřených sledování. Psychiatr. praxi 2011; 12(1): 22-26.
    14. Chemali Z, Chahine LM, Fricchione G. The use of selective serotonin reuptake inhibitors in elderly patients. Harv Rev Psychiatry 2009; 17(4): 242-253. Go to original source... Go to PubMed...
    15. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. The Lancet 2009; 373(9665): 746-758. Go to original source... Go to PubMed...
    16. Češková E. Léčba deprese ve stáří. Psychiatr. praxi 2011; 12(3): 100-104.
    17. Gottfries CG, Carlsson I, Nyth AL. Treatment of depression in elderly patients with and without dementia disorders. Int Clin Psychopharmacol 1992; 6(Suppl 5): 55-64. Go to original source... Go to PubMed...
    18. Lai MK, Tsang SW, Alder JT, et al. Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer´s disease. Psychopharmacology 2005; 179: 673-677. Go to original source... Go to PubMed...
    19. Alexopoulos GS, Streim J, Carpenter D, Docherty JP. The Expert Consensus Guidelines: Using antipsychotic agents in older patients. J Clin Psychiatry 2004; 65(Suppl 2): 1-105.
    20. Cummings, JL, McRae, T, Zhang, R. Effects of Donepezil on Neuropsychiatric Symptoms in Patients With Dementia and Severe Behavioral Disorders. Am J Geriatr psychiatry 2006; 14(7): 605-612. Go to original source... Go to PubMed...
    21. Gauthier S, Loft H, Cummings J. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. Int J Geriatr Psychiatry 2008; 23: 537-545. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.